Soybean oil API Manufacturers
compare suppliers & get competitive offers
Date | Seller | Exporter country | Buyer | Importer country | Product | Quantity (KG) | Price per KG | Latest transactions |
|---|---|---|---|---|---|---|---|---|
| 26-Aug-2024 | (Hidden) | 
Japan
| NISSEI ECO... | 
Vietnam
| NS09#&PLAS... | 1,008 | $ @36$-7! | Check all data |
| 09-Aug-2024 | (Hidden) |
Vietnam
| IAO SON HO... |
Vietnam
| EPOXIDIZED... | 600 | $ @36$-7! | |
| 09-Aug-2024 | (Hidden) | Taiwan (china) | ZHONG BU A... |
Vietnam
| NPL326#&EP... | 600 | $ @36$-7! |
Join our notification list by following this page.
Click the button below to find out more
Click the button below to switch over to the contract services area of Pharmaoffer.
Looking for Soybean oil API ?
- Description:
- Here you will find a list of producers, manufacturers and distributors of Soybean oil. You can filter on certificates such as GMP, FDA, CEP, Written Confirmation and more. Send inquiries for free and get in direct contact with the supplier of your choice.
- API | Excipient name:
- Soybean oil
- DrugBank number:
- DB09422
- Unique Ingredient Identifier:
- 241ATL177A
About Soybean oil
You can find a short description about Soybean oil here. Derived from soybeans, soybean oil is a common vegetable oil and a source of polyunsaturated and saturated fatty acids. It is a complex mixture of triglycerides where per 100 g, soybean oil has 16 g of saturated fat, 23 g of monounsaturated fat, and 58 g of polyunsaturated fat. The major component fatty acids are linoleic (48% - 58%), oleic (17% - 30%), palmitic (9% -13%), linolenic (4% - 11%), and stearic (2.
-0.05.0%). It is used as a cooking oil and lipid emulsion for parenteral nutrition in clinical settings. Soybean oil-based lipid emulsion is the only FDA-approved lipid formulation for clinical use.
You can ask the supplier about all relevant certificates for the product such as CoA, Safety Data Sheet and DMF.
Soybean oil is a type of Other lipid-lowering agents
Other lipid-lowering agents are a category of pharmaceutical active pharmaceutical ingredients (APIs) that are used to reduce elevated levels of lipids, such as cholesterol and triglycerides, in the bloodstream. These agents play a crucial role in managing conditions like hyperlipidemia and dyslipidemia, which are associated with an increased risk of cardiovascular diseases.
Within the category of other lipid-lowering agents, there are several API classes that offer diverse mechanisms of action. These include bile acid sequestrants, fibrates, and cholesterol absorption inhibitors. Bile acid sequestrants work by binding to bile acids in the intestines, preventing their reabsorption and leading to increased excretion of cholesterol. Fibrates primarily target triglyceride levels by activating a receptor that enhances the breakdown of triglycerides in the liver. Cholesterol absorption inhibitors, on the other hand, inhibit the absorption of dietary cholesterol in the intestines.
These lipid-lowering agents are typically prescribed alongside lifestyle modifications, such as adopting a healthy diet and engaging in regular physical activity. They are available in various formulations, including tablets and capsules, and are administered orally.
It is important to note that the use of other lipid-lowering agents should be done under the guidance of a healthcare professional, as they may have potential side effects and interactions with other medications. Common side effects include gastrointestinal discomfort, muscle pain, and liver function abnormalities.
In conclusion, other lipid-lowering agents form a crucial category of pharmaceutical APIs that are employed to reduce lipid levels in the body. They encompass a range of classes with distinct mechanisms of action, aiding in the management of hyperlipidemia and dyslipidemia. However, it is essential to consult with a healthcare provider for proper guidance and monitoring while using these agents.
